Menu
The New York stock exchanges closed with appreciation in the session on August 19, 2026, with the North American economic scenario dictating...
Die New Yorker Börsen schlossen in der Sitzung am 19. August 2026 mit einem Anstieg, wobei das nordamerikanische Wirtschaftsszenario das Tempo der...
Ein experimenteller personalisierter Krebsimpfstoff, der in Zusammenarbeit zwischen Merck und Moderna entwickelt wurde, hat in seiner ersten klinischen Spätphase sehr positive erste...
An experimental personalized cancer vaccine, developed in partnership between Merck and Moderna, has shown very positive initial results in its first late-phase...
Moderna and Merck have released promising results from late-stage research into the personalized mRNA vaccine intismeran. The treatment, combined with the immunotherapy...
Die Aktien des Pharmaunternehmens Moderna verzeichneten am Morgen des 19. August 2026 einen Anstieg von 95 % auf dem Finanzmarkt, was die...
Shares of the pharmaceutical company Moderna registered a 95% jump in the financial market on the morning of August 19, 2026, projecting...
Moderna reported on August 5 that the United States Food and Drug Administration (FDA) has granted approval for its new messenger RNA...
Sua privacidade
O Mix Vale usa cookies para medir audiência e exibir anúncios que sustentam a redação. Você escolhe. Saiba mais.